Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Author information

Affiliations

  • 1. Pierre & Marie Curie University, Department of Rheumatology, AP-HP Saint-Antoine Hospital, 184 rue du Faubourg Saint-Antoine, Paris 75012, France.
      Authors
    • Sellam J 1
    (1 author)

Nature reviews. Rheumatology, 05 Oct 2010, 6(11):625-635
https://doi.org/10.1038/nrrheum.2010.159 PMID: 20924410 

Review

Abstract 

Osteoarthritis (OA), one of the most common rheumatic disorders, is characterized by cartilage breakdown and by synovial inflammation that is directly linked to clinical symptoms such as joint swelling, synovitis and inflammatory pain. The gold-standard method for detecting synovitis is histological analysis of samples obtained by biopsy, but the noninvasive imaging techniques MRI and ultrasonography might also perform well. The inflammation of the synovial membrane that occurs in both the early and late phases of OA is associated with alterations in the adjacent cartilage that are similar to those seen in rheumatoid arthritis. Catabolic and proinflammatory mediators such as cytokines, nitric oxide, prostaglandin E(2) and neuropeptides are produced by the inflamed synovium and alter the balance of cartilage matrix degradation and repair, leading to excess production of the proteolytic enzymes responsible for cartilage breakdown. Cartilage alteration in turn amplifies synovial inflammation, creating a vicious circle. As synovitis is associated with clinical symptoms and also reflects joint degradation in OA, synovium-targeted therapy could help alleviate the symptoms of the disease and perhaps also prevent structural progression.

Full text links 

Read article at publisher's site: https://doi.org/10.1038/nrrheum.2010.159

References 

Articles referenced by this article (116)

Show 10 more references (10 of 116)

Citations & impact 

Impact metrics

720
Citations
Jump to Citations

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1038/nrrheum.2010.159

Supporting
Mentioning
Contrasting
18
950
0

Article citations

Go to all (720) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.